Stock Information
symbol line chart

ZEPPZepp Health Corporation

Upcoming Earnings

We were not able to find an announced earnings date for this symbol yet. Check back again later

Company Info

CEO

Wang Huang

Location

N/A, China

Exchange

NYSE

Website

https://huami.com

Summary

Zepp Health Corporation develops, manufactures, and sells smart wearable technological devices in the People's Republic of China.

Company Info

CEO

Wang Huang

Location

N/A, China

Exchange

NYSE

Website

https://huami.com

Summary

Zepp Health Corporation develops, manufactures, and sells smart wearable technological devices in the People's Republic of China.

AI Insights for ZEPP
2 min read

Quick Summary

Zepp Health Corporation, headquartered in China, is a technology company specializing in the development, manufacturing, and sale of smart wearable devices. It primarily offers products such as smart bands, smartwatches, and smart scales under its Amazfit brand and, through previous collaborations, the Xiaomi brand. Its customers range from individual consumers interested in health, wellness, and fitness tracking to athletes and tech enthusiasts globally. Zepp collects and analyzes user biometric and activity data, providing users with insightful charts and graphs for personal fitness optimization. The company also aims to enhance its devices with artificial intelligence features and integrate third-party solutions to cater to specific market segments like female athletes.

The Bull Case

  • Zepp Health’s key strengths include its ability to deliver innovative smart wearable products at competitive prices, backed by robust technology and R&D capabilities, especially in health and fitness monitoring.
  • The Amazfit brand is recognized globally, and the company demonstrates strong execution with consistent product launches that meet current consumer demands.
  • Its focus on integrating artificial intelligence into its devices, as well as strategic acquisitions like Wild.AI, enables Zepp to tailor offerings to niche markets such as female athletes.
  • Zepp has shown efficient cash management, successfully reducing debt while maintaining stable cash reserves.
  • Its multinational presence, especially in China and growing share in North America, further strengthens its market position.

The Bear Case

  • Zepp continues to operate at a net loss, with profitability hampered by high operating expenses and challenges in fully absorbing fixed costs during weaker sales periods.
  • The company’s gross margins, while improving, remain pressured by promotional pricing, chip shortages, and increased input costs.
  • Zepp’s business is somewhat seasonal, with lower sales in specific quarters contributing to operating inefficiencies.
  • Their dependence on supply chains and external manufacturing partners exposes them to potential disruptions.
  • Additionally, compared to larger, better-capitalized competitors like Apple and Samsung, Zepp has limited scale and brand presence in premier markets.

Key Risks

  • Key risks include ongoing global supply chain challenges and semiconductor shortages, which have caused shipment delays.
  • Zepp is exposed to tariff fluctuations and trade policy uncertainties, potentially raising costs or impacting market access.
  • The company operates in a highly competitive sector dominated by larger players with greater resources for R&D and marketing.
  • Economic downturns could reduce consumer discretionary spending, impacting wearable sales.

What to Watch

UpcomingIn the most recent quarter, Zepp Health reported a significant increase in revenue, notably a 78.5% year-over-year jump to $75.8M in Q3 2025, with strong sales from the Amazfit T-Rex 3 Pro.
UpcomingThe company achieved operating breakeven amid improving gross margins, although these margins were down year-over-year due to promotional activities and elevated chip costs.
UpcomingZepp continued to reduce its debt and executed share buybacks, bolstering its cash reserves.
ExpectedFor the next quarter, Zepp Health anticipates Q4 revenue to reach between $82 and $86 million, representing 38–45% year-over-year growth, buoyed by continued strong sales momentum and new product launches.

Price Drivers

  • Stock price is driven by quarterly earnings reports, revenue growth (notably triple-digit growth in recent quarters), and new product launches such as the Amazfit T-Rex 3 Pro and Active Max smartwatches.
  • Macroeconomic events such as tariff changes, global supply chain disruptions, and consumer demand trends for wearables also impact price movement.
  • Share repurchase programs, debt reduction efforts, and positive analyst sentiment towards small-cap stocks under $10 offer additional influence.
  • Unexpected challenges like chip shortages and tariff-related costs pose further volatility.

Recent News

  • Zepp Health has garnered attention for launching several new products, such as the Amazfit T-Rex 3 Pro and Active Max smartwatches, both aimed at tech-savvy and athletic consumers.
  • The company completed the acquisition of Wild.AI’s core assets, enhancing their offering for women’s wellness through advanced hormone-informed coaching, and plans to integrate these features into Amazfit devices.
  • News reports highlight Zepp’s ongoing share repurchase activities, successful debt reduction, improved gross margins, and partnerships with high-profile athletes.
  • Zepp has issued positive forward guidance on revenue growth and continued focus on research, marketing, and product innovation.

Market Trends

  • There is a sustained global trend toward health tracking, fitness monitoring, and personal wellness, fueling strong demand for smart wearables.
  • Consumers are increasingly seeking affordable yet feature-rich devices, heightening competition among established and emerging players.
  • Macroeconomic factors, including potential interest rate cuts and renewed investor interest in small-cap stocks, are creating a favorable environment for companies like Zepp.
  • Supply chain resiliency and adaptability to trade uncertainties remain critical industry themes.

AI-generated summary. Not investment advice. DYOR.

Community Research

Research from investors like you

Be the first to share your analysis on ZEPP

Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.

Topics: Company overview • Products • Competitors • Strengths & Risks

Symbol's posts

No more topics to show